Awakn Life Sciences Corp. (AWKNF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -2.38 Million | -7.36 Million | -8.58 Million | -472.88 Thousand |
| Net Income | -3.67 Million | -9.14 Million | -15.94 Million | -1.1 Million |
| Depreciation & Amortization | 18.29 Thousand | 603.53 Thousand | 181.41 Thousand | 12.92 Thousand |
| Deferred income taxes | - | -1.19 Million | -513.88 Thousand | - |
| Stock-based compensation | 813.71 Thousand | 628.23 Thousand | 1.09 Million | 39.87 Thousand |
| Change in working capital | 1.17 Million | 509.78 Thousand | 537.66 Thousand | 132.27 Thousand |
| Other non-cash items | -845.53 Thousand | 1.23 Million | 6.06 Million | 448.43 Thousand |
| Investing Cash Flow | -20.4 Thousand | -95.34 Thousand | -1.68 Million | -216.18 Thousand |
| Investments in PPE | - | -95.34 Thousand | -1.7 Million | -201.34 Thousand |
| Acquisitions | - | - | 21.65 Thousand | -14.83 Thousand |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -20.4 Thousand | -95.34 Thousand | -5000.00 | - |
| Financing Cash Flow | 2.45 Million | 6.4 Million | 11.5 Million | 1.05 Million |
| Debt repayment | - | -766.09 Thousand | -3.85 Million | -34.72 Thousand |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 2.65 Million | 5.97 Million | 7.82 Million | 1.09 Million |
| Other Financing Activities | -199.96 Thousand | 1.19 Million | 7.53 Million | 1.41 Million |
| Accounts receivables | 78.71 Thousand | -14.5 Thousand | -83.98 Thousand | - |
| Accounts payables | 896.39 Thousand | 650.04 Thousand | 1.02 Million | - |
| Inventory | - | - | - | - |
| Other working capital | 203.25 Thousand | -125.76 Thousand | -401.55 Thousand | -128.07 Thousand |
| Cash at beginning of period | 550.86 Thousand | 1.62 Million | 366.06 Thousand | - |
| Cash at end of period | 407.3 Thousand | 550.86 Thousand | 1.62 Million | 366.06 Thousand |
| Capital Expenditure | - | -95.34 Thousand | -1.7 Million | -201.34 Thousand |
| Effect of forex changes on cash | -13.47 Thousand | -16.93 Thousand | 27.25 Thousand | -2483.00 |
| Net cash flow / Change in cash | -143.56 Thousand | -1.07 Million | 1.25 Million | 366.06 Thousand |
| Free Cash Flow | -2.38 Million | -7.45 Million | -10.29 Million | -674.23 Thousand |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.31 Million | -3.67 Million | -647.23 Thousand | -1.15 Million | -1.58 Million | -2.65 Million |
| Depreciation & Amortization | 4768.00 | 18.29 Thousand | 6306.00 | 3611.00 | 171.19 Thousand | 159.45 Thousand |
| Deferred income taxes | - | - | -140.17 Thousand | -736.99 Thousand | 129.32 Thousand | -821.28 Thousand |
| Stock-based compensation | 93.7 Thousand | 813.71 Thousand | 67.92 Thousand | 572.57 Thousand | 79.5 Thousand | 213.55 Thousand |
| Change in working capital | 698.4 Thousand | 1.17 Million | -114.46 Thousand | -46.07 Thousand | 640.5 Thousand | -399.74 Thousand |
| Other non-cash items | -118.37 Thousand | -845.53 Thousand | 172.68 Thousand | 484.43 Thousand | -184.73 Thousand | 1.65 Million |
| Investing Cash Flow | 20.4 Thousand | -20.4 Thousand | - | 49.86 Thousand | -70.26 Thousand | 941.00 |
| Investments in PPE | - | - | - | 70.26 Thousand | -70.26 Thousand | 941.00 |
| Acquisitions | -60.73 Thousand | - | - | 60.73 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 60.73 Thousand | -20.4 Thousand | - | -81.14 Thousand | -70.26 Thousand | 941.00 |
| Financing Cash Flow | -32.99 Thousand | 2.45 Million | 764.71 Thousand | 755.12 Thousand | 969.2 Thousand | 1.68 Million |
| Debt repayment | - | - | - | - | -111.89 Thousand | -15.7 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -78.69 Thousand | - | - | - | - | - |
| Common Stock Issuance | -32.99 Thousand | 2.65 Million | 764.71 Thousand | 843.2 Thousand | 1.08 Million | 1.79 Million |
| Other Financing Activities | 45.69 Thousand | -199.96 Thousand | 764.71 Thousand | -88.07 Thousand | 1.08 Million | -96.01 Thousand |
| Accounts receivables | 322.74 Thousand | 78.71 Thousand | -74.15 Thousand | -95.41 Thousand | -74.45 Thousand | 127.1 Thousand |
| Accounts payables | 317.99 Thousand | 896.39 Thousand | 14.51 Thousand | -61.78 Thousand | 625.66 Thousand | -415.92 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 57.66 Thousand | 203.25 Thousand | -54.82 Thousand | 111.12 Thousand | 89.29 Thousand | -110.93 Thousand |
| Cash at beginning of period | 554.65 Thousand | 550.86 Thousand | 429.78 Thousand | 389.69 Thousand | 550.86 Thousand | 1.13 Million |
| Cash at end of period | 407.3 Thousand | 407.3 Thousand | 554.65 Thousand | 429.78 Thousand | 389.69 Thousand | 550.86 Thousand |
| Capital Expenditure | - | - | - | 70.26 Thousand | -70.26 Thousand | 941.00 |
| Effect of forex changes on cash | -14.94 Thousand | -13.47 Thousand | 15.12 Thousand | 293.25 Thousand | -306.9 Thousand | -412.97 Thousand |
| Net cash flow / Change in cash | -147.35 Thousand | -143.56 Thousand | 124.87 Thousand | 40.08 Thousand | -161.17 Thousand | -581.72 Thousand |
| Free Cash Flow | -99.41 Thousand | -2.38 Million | -654.96 Thousand | -803.57 Thousand | -823.46 Thousand | -1.85 Million |
BLOIN
TCC
TIMESGTY
BOMTALKIES
002937
000975